There may be light at the end of the tunnel regarding Medicare payments for studies with the PET radioisotope fluorodeoxyglucose (FDG). The Health Care Financing Administration last month informed members of the Institute for Clinical PET that the agency
There may be light at the end of the tunnel regarding Medicare payments for studies with the PET radioisotope fluorodeoxyglucose (FDG). The Health Care Financing Administration last month informed members of the Institute for Clinical PET that the agency is preparing to make a positive recommendation covering Medicare reimbursement for the use of FDG in lung cancer studies.
HCFA's move would be the first time that the agency has allowed Medicare payment for FDG studies, and it could help spark the still-developing market for clinical PET. It is also expected to increase demand for high-energy imaging on conventional gamma cameras, such as with coincidence detection techniques.
Sources close to the ICP indicate that HCFA has agreed to forward its recommendation in the next 60 to 90 days to intermediary insurance companies that actually make payments to Medicare beneficiaries. The level of reimbursement and whether it will be set at different levels for conventional PET and coincidence detection exams are still unknown.
In another bit of good news for PET advocates, legislation that would strip the Food and Drug Administration of its power to regulate cyclotron-produced radioisotopes passed the Senate in September and appeared headed for victory in the House of Representatives as well. The bill is part of legislation to reform the FDA, and it would mandate that cyclotron-produced radioisotopes be regulated under state practice of pharmacy rules.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.